Not compatible with Internet Explorer
Not compatible with Internet Explorer
Not compatible with Internet Explorer
Investors
Kadimastem on Tel-Aviv Stock Exchange
For More Investors Info.
Kadimastem Granted a Patent in Israel for the Treatment of ALS
March 9, 2021, 9:00:16 AM
Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of AstroRx® for ALS
December 15, 2020, 1:56:27 PM
Kadimastem Reports Positive Interim Results of Cohort B of its AstroRx® Phase 1/2a Clinical Trial in
August 3, 2020, 7:11:53 AM
Kadimastem Appoints Ruth Alon as Chairperson of the Company's Board of Directors
January 31, 2021, 6:10:19 AM
Kadimastem Announces Promising Results of Cohort A of its Phase 1/2a Clinical Trial in ALS
July 27, 2020, 1:25:35 PM
Kadimastem Announces the Completion of Treatment for Cohort B
July 27, 2020, 1:25:54 PM
Successful Preclinical results of our Cell Therapy Treatment for Insulin-Dependent Diabetes
July 27, 2020, 1:27:08 PM
Kadimastem to Submit an Amendment of its ALS Phase 1/2a Clinical Trial Protocol
July 27, 2020, 1:28:11 PM
Kadimastem to Present at the 7th International Stem Cell Meeting, in Tel-Aviv
November 17, 2019, 2:10:12 PM
Kadimastem Announces Promising Interim Results of Cohort A of its Phase 1/2a Clinical Trial in ALS
July 27, 2020, 1:30:03 PM
Kadimastem receives Approval from the Ministry of Health of Israel to continue its trial of AstroRX®
April 18, 2019, 1:45:49 PM
Kadimastem Announces the Completion of Cell Transplantation of AstroRx® in ALS Patients for Cohort A
February 24, 2019, 7:48:37 AM
2019 Israel Innovation Authority Budget Approved for Kadimastem: NIS 13.6 M for ALS Project
February 17, 2019, 8:00:17 AM
Success for Kadimastem: 97% of Warrants (Series 4) Exercised for NIS 3.6M
November 14, 2018, 2:48:21 PM
Kadimastem and Defymed Awarded Grant for the Development of a Product for the Treatment of Diabetes
November 12, 2018, 2:48:44 PM
FDA Granted Kadimastem Orphan Drug Status for AstroRx® for the Treatment of ALS
November 4, 2018, 2:47:51 PM
Medical Breakthrough on a Global Scale and Significant Achievement for Kadimastem:
October 9, 2018, 9:47:57 AM
Altshuler Shaham and Company Stakeholders Lead $5.15 Million Investment in Kadimastem
October 2, 2018, 1:47:28 PM
Kadimastem and The AFDR Selected to Receive a bi-National Grant
July 2, 2018, 1:47:12 PM
Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial
July 1, 2018, 1:46:48 PM
Kadimastem was honored with a prize for excellence for the presentation of the company's technology
June 27, 2018, 1:46:28 PM
Initiation of coverage report on Kadimastem by global research firm Frost & Sullivan:
January 7, 2019, 8:15:36 AM
Scientific Article by Kadimastem: Cell-Based Treatment for ALS was Published
June 6, 2018, 7:21:11 AM
Kadimastem Announces the Enrollment of the First Patient for Its Clinical Trial in ALS Patients
April 26, 2018, 7:47:21 AM
Kadimastem Collaborates with French SME Defymed to Validate a Combined Solution for Type 1 Diabetes
April 21, 2018, 9:00:00 PM
Successful Rights Offering for Kadimastem; Raised NIS 5.1M
November 13, 2014, 2:45:07 PM
Kadimastem to collaborate with Merck Serono to advance efforts in neurodegenerative diseases
August 3, 2014, 12:40:37 PM
Chief Scientist Increases Budget to Advance Kadimastem's Cell Therapy for ALS
June 20, 2014, 12:35:36 PM
Success in Kadimastem’s First Pre-Clinical Trial for Treatment of Amyotrophic Lateral Sclerosis (ALS
June 18, 2014, 12:26:06 PM
Leading pharma entrepreneur Avi Meizler believes in Kadimastem!
March 19, 2014, 10:23:02 AM
Kadimastem announces its intention to reduce the exercise price for warrants (Series 1)
February 3, 2014, 10:20:55 AM
Kadimastem has received approval from the OCS to promote cell therapy
December 23, 2013, 10:05:45 AM
Merck Serono and Kadimastem MOU on Drug Screening and Discovery for Neurodegenerative Diseases
November 4, 2013, 10:02:26 AM
Kadimastem successfully completes an IPO and raised $5.5 Million USD
June 9, 2013, 8:59:08 AM
Pharmaceutical Company Merck Serono signs an agreement: Use Kadimastem's platform for drug screening
April 4, 2012, 8:57:29 AM